A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)
Clinical trial NCT03731182 · COMPLETED
Trial details
- NCT number
- NCT03731182
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-23
- Primary completion
- 2020-06-08
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.